Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

Urinary incontinence (UI) and overactive bladder (OAB) are more common adverse health outcomes in patients who have ...

Social determinants of health (SDOH) were found to be associated with increased risk of heart failure (HF) and ventricular arrhythmias (VA) in patients with hypertrophic cardiomyopathy (HCM), ...

Higher nighttime light exposure is associated with increased light sleep duration, with complex effects on deep sleep duration. New research reveals how outdoor nighttime light exposure subtly impacts ...

The CDC's shared decision-making approach for vaccinations is misunderstood, leading to public confusion and potential undermining of vaccine confidence. Surveys show many Americans incorrectly ...

Managed care organization and providers should conduct early formulary reviews and education to ensure rapid access to dextromethorphan-bupropion upon approval, potentially delaying facility placement ...

Following the FDA approval of rilzabrutinib (Wayrilz; Sanofi) for immune thrombocytopenia (ITP), a rare autoimmune disorder, David Kuter, MD, DPhil, highlights the most pressing a ...

Recent trials highlight T-DXd's superior efficacy and manageable toxicity in treating high-risk HER2-positive breast cancer, reshaping treatment strategies.

A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction (MI) and preserved left ventricular ejection fraction (LVEF) found this ...

Managed care organizations should evolve cost models to capture savings from dextromethorphan-bupropion’s safety profile, which avoids costly complications associated with traditional Alzheimer ...

The poster, presented by William Audeh, MD, MS, chief medical officer of Agendia, cited results from the MammaPrint, ...